Lakewood-Amedex Biotherapeutics(LABT.US)

Last Updated 19:00:00 ET
longbridge loading

Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update

Fidelity·
US
LABT
+2.38%
Fidelity·
US
LABT
+2.38%

Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers | LABT Stock News

StockTitan·
US
LABT
+2.38%
StockTitan·
US
LABT
+2.38%

Lakewood-Amedex (LABT.US) Surges 25% Intraday

Movers Alert·
US
LABT
+2.38%
Movers Alert·
US
LABT
+2.38%

Lakewood-Amedex Soars Over 53% Amid Board Appointment

Movers Alert·
US
LABT
+2.38%
Movers Alert·
US
LABT
+2.38%

Pre-market hot trades in US stocks: Lakewood-Amedex Biotherapeutics up 54.51% in pre-market; Galaxy Digital up 3.00% in pre-market

Price Alert·
US
LABT
+2.38%
US
GLXY
+3.42%
Price Alert·
US
LABT
+2.38%
US
GLXY
+3.42%

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors | ENVB Stock News

StockTitan·
US
ENVB
-4.09%
US
IBB
-0.10%
US
BBH
-0.44%
StockTitan·
US
ENVB
-4.09%
US
IBB
-0.10%
US
BBH
-0.44%
© 2026 Longbridge｜Disclaimer